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Random and combinatorial 
mutagenesis for improved total 
production of secretory target 
protein in Escherichia coli
David Gonzalez‑Perez1,2, James Ratcliffe1, Shu Khan Tan1, Mary Chen May Wong1, Yi Pei Yee1, 
Natsai Nyabadza1, Jian‑He Xu3, Tuck Seng Wong1,4* & Kang Lan Tee1*
Signal peptides and secretory carrier proteins are commonly used to secrete heterologous 
recombinant protein in Gram‑negative bacteria. The Escherichia coli osmotically‑inducible protein 
Y (OsmY) is a carrier protein that secretes a target protein extracellularly, and we have previously 
applied it in the Bacterial Extracellular Protein Secretion System (BENNY) to accelerate directed 
evolution. In this study, we reported the first application of random and combinatorial mutagenesis 
on a carrier protein to enhance total secretory target protein production. After one round of random 
mutagenesis followed by combining the mutations found, OsmY(M3) (L6P, V43A, S154R, V191E) 
was identified as the best carrier protein. OsmY(M3) produced 3.1 ± 0.3 fold and 2.9 ± 0.8 fold more 
secretory Tfu0937 β‑glucosidase than its wildtype counterpart in E. coli strains BL21(DE3) and 
C41(DE3), respectively. OsmY(M3) also produced more secretory Tfu0937 at different cultivation 
temperatures (37 °C, 30 °C and 25 °C) compared to the wildtype. Subcellular fractionation of the 
expressed protein confirmed the essential role of OsmY in protein secretion. Up to 80.8 ± 12.2% of 
total soluble protein was secreted after 15 h of cultivation. When fused to a red fluorescent protein 
or a lipase from Bacillus subtillis, OsmY(M3) also produced more secretory protein compared to the 
wildtype. In this study, OsmY(M3) variant improved the extracellular production of three proteins 
originating from diverse organisms and with diverse properties, clearly demonstrating its wide‑
ranging applications. The use of random and combinatorial mutagenesis on the carrier protein 
demonstrated in this work can also be further extended to evolve other signal peptides or carrier 
proteins for secretory protein production in E. coli.
Abbreviations
dATP  Deoxyadenosine triphosphate
dCTP  Deoxycytidine triphosphate
dGTP  Deoxyguanosine triphosphate
dNTP  Deoxynucleotide
dTTP  Deoxythymidine triphosphate
DyP4  Dye-decolorizing peroxidase 4 from Pleurotus ostreatus strain PC15
Em  Emission wavelength
E. coli  Escherichia coli
Ex  Excitation wavelength
epPCR  Error-prone polymerase chain reaction
HTS  High-throughput screening
Mw  Molecular weight
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pNPA  p-Nitrophenyl acetate
pNPG  p-Nitrophenyl-β-d-glucopyranoside
OD600  Optical density at 600 nm
OsmY  Osmotically-inducible protein Y
PCR  Polymerase chain reaction
RFP  Red fluorescent protein
WT  Wildtype
Protein secretion in Gram‑negative bacteria. Recombinant protein production, including technical 
enzymes and biopharmaceutical proteins, is a growing multi-billion-dollar market. Different eukaryotic and 
prokaryotic hosts are currently used for recombinant protein production, including mammalian cells, fungi, 
yeast and bacteria. Bacteria are especially attractive for their fast growth rates, ease in handling, broad range of 
carbon sources and relatively low-cost culture medium. Well-established and widely accessible genetic manipu-
lation tools are also available, especially for the Gram-negative bacterium Escherichia coli1.
Gram-positive bacteria can secrete native proteins or proteins that originate from close relatives at high  yield2. 
However, their compatibility with other proteins is low and the presence of extracellular proteolytic degradation 
is a challenge for product quality assurance. In contrast, Gram-negative bacteria produce a broad range of heter-
ologous proteins. Protein secretion in Gram-negative bacteria is less common compared to other organisms like 
Gram-positive bacteria, yeast and fungi. However, it offers several advantages. First, Gram-negative bacteria, like 
E. coli, secretes few native proteins to provide a relatively pure background for heterologous protein production. 
Second, no cell disruption is required, hence reducing the complexity and the cost of downstream processing. 
Third, protein secretion out of the cytoplasm provides an oxidizing environment that facilitates disulphide bond 
formation and protein folding, for example during hormones and antibody fragments production. Fourth, toxic 
effect of some target proteins on the production host can be alleviated when the protein is secreted out of the cell.
Protein secretion in Gram-negative bacteria can be achieved by fusing a signal peptide or a secretory carrier 
to the N- or C-terminus of the target  protein3,4. Enhancing protein secretion is a challenge as it is currently not 
possible to predict the performance of a signal peptide or a secretory carrier for a specific target protein or host. 
Three approaches are generally used for secretory protein production in E. coli. The first approach is to screen 
a large library of signal peptides and secretory  carriers5,6 to identify a fusion partner for optimal secretion. The 
second approach is to engineer the signal peptides or the transporter proteins for a better extracellular heterolo-
gous protein production in E. coli. Examples include: (i) inserting short random peptides libraries (1–13 amino 
acids) at the junction between the signal peptide and the mature protein followed by screening for the construct 
that secreted most protein to the E. coli  periplasm7, (ii) screening error-prone mutagenesis library of an ABC 
transporter from Pseudomonas fluorescens to enhance its extracellular secretion efficiency in E. coli8, (iii) directed 
evolution of translation initiation region without altering the amino acid sequence of signal peptide to enhance 
protein secretion into the E. coli  periplasm9, and (iv) using non-optimal codons in the signal sequence of TolB 
for a better extracellular protein secretion in E. coli10. The third approach involves engineering the protein pro-
duction host, for instance, perturbing the cell wall peptidoglycan network via deletion of dacA and dacB11 and 
screening E. coli single-gene knockout library for hypersecretory  phenotypes12.
The osmotically‑inducible protein Y from Escherichia coli. The E. coli osmotically-inducible protein 
Y (OsmY) is expressed in response to a variety of stress conditions, especially osmotic  shock13–15. OsmY was 
selected for this work as it was identified as the most efficient fusion partner for extracellular protein secretion 
among the naturally excreted protein in E. coli BL21(DE3)16. OsmY has two BON (bacterial OsmY and nodula-
tion) domains; one between amino acids 55–123 and the second between amino acids 134–201. The BON domain 
is a conserved domain that has typically about 60 amino acid residues, and has an α/β predicted fold. The exact 
function of the BON domain is unclear, but it is predicted to be a phospholipid binding domain that explains 
OsmY’s secretory  function17. Numerous studies used OsmY for extracellular production of recombinant pro-
teins in E. coli, including  endoglucanase18, β-glucosidase18,  xylanase19,20,  xylosidase19,20, single-chain  antibody21 
and various human  proteins22. We also incorporated OsmY in the Bacterial Extracellular Protein Secretion Sys-
tem (BENNY) to accelerate the directed evolution workflow in engineering DyP4, a heme  peroxidase23. OsmY 
was previously reported to show chaperone activity and helped optimized unstable protein folding in vivo24. The 
versatility of OsmY further prompted us to engineer this protein to expand its application.
In this study, we demonstrated the first successful example of applying random and combinatorial mutagenesis 
on a secretory carrier to enhance total secretory target protein production in E. coli. There are two mechanisms 
by which total secretory target protein production can be enhanced: (a) increasing the secretion capability of 
a carrier (i.e., altering protein partition by favouring extracellular secretion), and (b) increasing the expression 
level of the target protein carrying a secretion signal such as a carrier. OsmY is strategically chosen, as it has the 
potential to satisfy either or both requirements.
Results and discussion
Random mutagenesis of OsmY. To evolve OsmY for a higher total secretory protein production, 
β-glucosidase Tfu0937 from Thermobifida fusca YX was selected as the secretion target protein for its validated 
application in cellulose degradation and ease of monitoring enzymatic activity. OsmY can secrete proteins in 
different Escherichia coli  strains16. The levels of total secreted OsmY-Tfu0937 produced by E. coli C41(DE3) 
and BL21(DE3) were first measured using the p-nitrophenyl-β-d-glucopyranoside (pNPG) assay to identify the 
more efficient strain. C41(DE3) cultivation gave higher OsmY-Tfu0937 activity in the spent medium compared 
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to BL21(DE3), and was therefore chosen for subsequent mutagenesis experiments. The pNPG assay was adapted 
to a 96-well format. The final optimised assay had an apparent coefficient of variance of 19.7% (Fig. 1a), sufficient 
for a high throughput screening. The enzymatic activity of secreted OsmY-Tfu0937 using pNPG as a pseudosub-
strate was also directly proportional to the volume of spent medium, when 5–50 µL was used (Fig. 1b). Variable 
volume of spent medium was thus used to keep the assay within the linear detection range, especially for OsmY 
variants with higher total secretory protein production.
During random mutagenesis, mutations were only targeted to the sequence encoding for OsmY, leaving 
the Tfu0937 sequence unaltered. This was designed to ensure all improvements can be attributed to OsmY and 
were not due to changes in the target protein, Tfu0937. The libraries were created using two different conditions 
with high and low mutagenic rates (Fig. 2). The effects of different mutagenic rates were evident in the activity 
of the clones in the library. For the low mutagenic rate library (Fig. 2a), 31% of clones had the same activity as 
the parent (i.e., one standard deviation above and below the average of parental clones) and 30% of clones were 
more active than the parent (i.e., greater than one standard deviation above the parent average). For the high 
mutagenic rate library (Fig. 2b), 16% of clones had the same activity as the parent and 21% of clones were more 
active than the parent. More inactive clones were also found in the high mutagenic rate library (23%) compared 
to the low mutagenic rate library (5%).
Improved OsmY mutants obtained from both random mutagenesis libraries. About three 
hundred clones from the two random mutagenesis libraries were screened and four improved variants were 
identified (Table 1). These four variants were subsequently cultivated in 5-mL tube cultures and extracellular 
OsmY-Tfu0937 activity was measured again to confirm their improvements as shown in Table 1. Mutations in 
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Figure 1.  The OsmY(WT)-Tfu0937 activity in the spent medium was measured with the pNPG assay using an 
absorbance at 405 nm. (a) The pNPG assay was performed in a 96-well microplate for OsmY(WT)-Tfu0937-
expressing C41(DE3) cells cultivated in a 96-well deep well plates. The coefficient of variance was calculated 
using the absolute values measured at 405 nm. (b) The pNPG assay was conducted using 5–50 µL of spent 






















































Figure 2.  The OsmY-Tfu0937 activity in the spent medium of epPCR generated OsmY mutagenesis libraries 
was measured in a 96-well microplate. The activity was measured with the pNPG assay using an absorbance at 
405 nm. The libraries were generated using (a) a low and (b) a high mutagenic rates. The activities of parental 
clones in column 6 were measured in the same 96-well microplate. The average of parental clones is shown as a 
solid red line and one standard deviation above and below the average are shown as dash red lines.
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of extracellular OsmY-Tfu0937 production as OsmY(TOA4) > OsmY(S19C) > OsmY(A39) > OsmY(V43A) > Os
mY(WT). In agreement with the mutagenic conditions, the three variants from the low mutagenic rate library 
have a single nucleotide substitution each, while the one variant from the high mutagenic rate library has four 
nucleotide substitutions.
OsmY is a 201-amino acid protein with an N-terminal 28-amino acid signal peptide. Interestingly, the top 
two variants have mutations in their signal peptides; L6P for OsmY(TOA4) and S19C for OsmY(S19C). It was 
previously shown that the OsmY signal peptide secreted protein into the periplasm, but the full length OsmY 
protein was required for extracellular protein  secretion16. Signal peptides have a conserved tripartite overall 
structure, which consists of a positively charged amino-terminal region, a central hydrophobic core, and a polar 
carboxyl-terminal  region25. The mutations L6P and S19C conserved the respective hydrophobic and polar nature 
of the amino acids. Variant OsmY(A39) has a silent mutation that changes the codon for A39 from GCG → GCT. 
Interestingly, codon GCG has the highest usage frequency among the four codons for alanine while GCT has the 
lowest usage frequency. The same was observed for the K107 silent mutation in OsmY(TOA4), where the higher 
usage frequency codon (AAA) was mutated to the lower usage frequency codon (AAG) for lysine. Non-optimal 
codon in the signal peptide had been reported to slow down the kinetics of translation to positively impact secre-
tion  efficiency10. The enhanced production of secretory protein by a switch to less optimal codons in A39 and 
K107 could potentially also be due to a slower translation kinetics. Important to note, codon deoptimization of 
signal peptides also improved the production of secretory protein in baculovirus/insect cell expression  system26. 
Our random mutagenesis data, along with the results from other signal peptide engineering studies, allow us 
to propose engineering strategies to guide future improvement of secretory protein production across various 
protein expression systems: (a) preserving the tripartite nature of the signal peptides through conservative muta-
tions, and (b) slowing the protein translation by deoptimizing the codons of the carrier protein.
Variant from random mutagenesis produced 1.8‑times more extracellular protein. The three 
variants with missense mutations [OsmY(TOA4), OsmY(S19C), and OsmY(V43A)] were re-transformed into 
C41(DE3) to rule out any possible effects due to host strain instability. In 50-mL flask cultivations, secreted pro-
tein was detected 5.5 h after culture inoculation, however significant activity was observed after 24 h of cultiva-
tion. Results (Fig. 3a) showed that variant OsmY(TOA4) had 1.8 ± 0.5 times more OsmY-Tfu0937 activity in the 
spent medium compared to the OsmY(WT) after 24 h cultivation, and this improvement increased further to 
2.2 ± 0.3 times after 48 h. Enhanced secretory protein production did not affect the cell viability, reflected by the 
similar cell growth of E. coli expressing OsmY(WT)-Tfu0937 and the variants.
Tfu0937 secretion by OsmY(WT) and OsmY(TOA4) were also compared at cultivation temperatures of 
25 °C and 30 °C (Fig. 3b). OsmY(TOA4) was more efficient than wildtype at these lower temperatures in secre-
tory protein production. When cultivated at 25 °C, OsmY-Tfu0937 activity in the spent medium remained low 
throughout the cultivation, likely due to the slower growth and protein production rates compared to cultivation 
at higher temperatures. However, more extracellular activity was detected for the OsmY(TOA4) variant than the 
OsmY(WT) after 27 h. When cultivated at 30 °C, OsmY-Tfu0937 activity in the spent medium of OsmY(TOA4) 
was 1.8 ± 0.2 times (23.0 h) and 1.5 ± 0.1 times (27.0 h) that of the wildtype, similar to the improvement seen at 
37 °C cultivation (Fig. 3a). As in the 37 °C cultivation, there was no significant difference in cell growth between 
OsmY(TOA4) and OsmY(WT) at 30 °C or at 25 °C. However, higher final cell optical densities were obtained 
at lower temperatures, potentially due to lower protein production load.
L6P is the beneficial mutation in OsmY(TOA4) variant. OsmY(TOA4) was the best variant identi-
fied from our initial screening. It has three missense mutations (L6P, S154R, V191E), with one located in the 
signal peptide (L6P) and the remaining two in the second BON domain. A single mutant was created for each 
of these mutations using site-directed mutagenesis and their extracellular OsmY-Tfu0937 activity was meas-
ured to deconvolute their effects on secretory protein production (Fig. 4). The two single mutants, S154R and 
V191E, showed the same OsmY-Tfu0937 activity in the spent medium as the wildtype OsmY. However, the L6P 
single mutant showed 3.1 ± 1.6 times the level of secreted protein compared to the wildtype OsmY after 24.0 h 
cultivation. Comparing the secretory protein production levels achieved by OsmY(TOA4) and OsmY(L6P), 
1.8 ± 0.5 times and 3.1 ± 1.6 times respectively, both variants secreted similar amount of proteins. There was 
Table 1.  OsmY variants identified from screening of epPCR libraries. The mutations were verified by DNA 
sequencing. a Variants were cultivated in 5-mL tubes cultures and activity of extracellular OsmY-Tfu0937 was 
determined with the pNPG assay using an absorbance at 405 nm, and compared with the wildtype OsmY-
Tfu0937.
Mutagenic rate Variant name Missense mutation Silent mutation Relative activity compared to OsmY  wildtypea
n.a OsmY(WT) n.a n.a 1.00 ± 0.08
Low OsmY(S19C) S19C (A → T) n.a 3.40 ± 0.25
Low OsmY(V43A) V43A (T → C) n.a 1.41 ± 0.13
Low OsmY(A39) n.a A39 (G → T) 1.67 ± 0.16
High OsmY(TOA4)
L6P (T → C)
S154R (A → C)
V191E (T → A)
K107 (A → G) 5.50 ± 0.56
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no additive interaction between S154R or V191E with L6P to further increase secretory protein production in 
OsmY(TOA4). The cell growth of the three single mutants were similar to the OsmY(WT), as was observed for 
OsmY(TOA4) (Supplementary Fig. S1). Our data indicated that the signal peptide of OsmY plays a greater role 
in secretory protein production compared to its BON domain.
Combinatorial mutagenesis further enhanced total secretory protein production. Site-directed 
mutagenesis was used to add the mutations S19C and V43A individually to the best variant OsmY(TOA4), creat-
ing mutants OsmY(M1) (i.e., TOA4 + S19C) and OsmY(M3) (i.e., TOA4 + V43A), respectively. When cultivated 
at the same conditions used in Fig. 3a, OsmY(M3) resulted in 2.9 ± 0.8 times more secretory protein compared to 
OsmY(WT) at 24 h (Supplementary Fig. S2). As with the earlier experiments, cell growth of variant OsmY(M3) 
was similar to that of OsmY(WT). Contrary to OsmY(M3), the spent medium of variant OsmY(M1) showed 
no OsmY-Tfu0937 activity, though its cell growth was similar to OsmY(WT). To determine if OsmY(M1) had 
loss only its protein secretion capability or also protein expression, enzymatic lysis with lysozyme was used to 
extract the intracellular soluble protein in OsmY(M1). The extracted soluble protein showed no OsmY-Tfu0937 
activity, suggesting the loss of soluble OsmY-Tfu0937 expression in variant OsmY(M1). We subsequently also 
added S19C to variant OsmY(M3) and observed the same effect, where no secreted OsmY-Tfu0937 activity was 






































































Figure 3.  Characterization of improved OsmY variants in 50-mL flask cultures. The OsmY-Tfu0937 activity, 
measured with the pNPG assay using an absorbance at 405 nm (left axis), are plotted as bars. The cell optical 
densities monitored at 600 nm (right axis) are shown as symbols. Cultures were inoculated using 1:100 
dilution. (a) OsmY(WT) and variants were expressed using C41(DE3) in 2 × TY auto-induction media and at 
37 °C and 200 rpm. The bars and symbols of the variants are represented using different colours; OsmY(WT) 
(black), OsmY(V43A) (blue), OsmY(S19C) (orange) and OsmY(TOA4) (red). Experiments were performed 
in triplicate. (b) OsmY(WT)-Tfu0937 and OsmY(TOA4)-Tfu0937 were expressed using C41(DE3) in 2 × TY 
auto-induction media, at 30 °C or 25 °C, and 200 rpm. The bars and symbols of the sample are represented 
using different colours; OsmY(WT) at 30 °C (black), OsmY(TOA4) at 30 °C (red), OsmY(WT) at 25 °C (grey), 
OsmY(TOA4) at 25 °C (magenta).























Figure 4.  The OsmY-Tfu0937 activity in the spent medium of single site-directed mutants was measured with 
the pNPG assay using an absorbance at 405 nm. Cells were cultivated in 20-mL of 2 × TY auto-induction media 
at 37 °C. Culture was inoculated using 1:100 dilution and 0.5 mL culture was sampled at various time points for 
activity assay. Experiments were performed in triplicate. The samples are represented using different colours; 
OsmY(WT)—black line, OsmY(L6P)—blue line, OsmY(S154R)—orange line and OsmY(V191E)—red line.
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detected. We therefore concluded that combining S19C with the existing mutations in OsmY(TOA4) led to 
negative epistatic interaction and loss of soluble protein expression.
OsmY is required for extracellular protein secretion in E. coli. Tfu0937 was found in the secretome 
of T. fusca27. To confirm that OsmY is necessary for the secretion of Tfu0937 in E. coli and to rule out the 
possibilities that this is solely due to cell leakage or the presence of a secretion motif in Tfu0937 recognized 
by E. coli, the plasmid pET24a-Tfu0937 was constructed. Plasmids pET24a-Tfu0937 and pET24a-OsmY(M3)-
Tfu0937 were used for protein expression. When Tfu0937 was expressed without OsmY using plasmid pET24a-
Tfu0937, the extracellular Tfu0937 activity constituted only 1.8 ± 0.3% of the total Tfu0937 activity in the three 
fractions (Fig. 5). Most of the Tfu0937 activity was found in the periplasmic fraction while the cytoplasmic frac-
tion accounted for 18.8 ± 3.1% of total Tfu0937 activity. In contrast, 80.8 ± 12.2% of total OsmY-Tfu0937 activity 
was found in the spent medium when OsmY(M3) was fused to the N-terminus of Tfu0937 (Fig. 5).
OsmY(M3) variant increased the total protein production. The increased extracellular OsmY-
Tfu0937 observed in OsmY(M3) compared to wildtype can be attributed to one or both of these factors: (1) 
higher fractional secretion of total protein, and (2) increase in total protein expression. To understand the rea-
son behind higher secretory protein production by OsmY(M3), we performed subcellular fractionation for 
OsmY(WT) and OsmY(M3) at two different time points during cultivation (6 h and 24 h). After 6 h cultiva-
tion, when cells were in the exponential growth phase, both wildtype and OsmY(M3) showed the most OsmY-
Tfu0937 activity in the cytoplasmic fraction, followed by the periplasmic fraction and the least activity was 
detected in the secreted fraction (Fig. 6). The wildtype strain has a higher fraction of OsmY-Tfu0937 found 
extracellularly and in the periplasm compared to OsmY(M3). However, the OsmY(M3) variant had 3.64 ± 0.13 
times more total OsmY-Tfu0937 activity compared to OsmY(WT). After 24 h cultivation, both wildtype and 
variant showed similar protein distribution in the extracellular, periplasmic and cytoplasmic fractions (Fig. 6). 
However, 2.73 ± 0.24 times more total OsmY-Tfu0937 activity was measured in OsmY(M3) compared to the 
wildtype. A total of 4100 U/mL of extracellular OsmY(M3)-Tfu0937 was produced after 24 h of cultivation. The 
enhanced production of secretory protein in OsmY(M3) was thus largely attributed to higher OsmY-Tfu0937 
expression in the variant, while its secretion capability is retained.
OsmY(M3) variant improves the production of secretory protein in both BL21(DE3) and 
C41(DE3) strains. The E. coli strain C41(DE3) was used for screening the mutagenesis libraries, where 
OsmY(TOA4) was obtained and OsmY(M3) was subsequently derived. Since OsmY(WT) can secrete OsmY-
Tfu0937 in both E. coli BL21(DE3) and C41(DE3) strains, we wanted to determine if the enhanced secretory 





































80.8 ± 12.2%79.4 ± 19.2%
18.8 ± 3.1%
1.8 ± 0.3%
Figure 5.  Subcellular localization of Tfu0937 and OsmY(M3)-Tfu0937. Proteins were expressed using 
pET24a-Tfu0937 and pET24a-OsmY(M3)-Tfu0937 in 2 × TY auto-induction medium at 37 °C for 15 h. The 
fractional Tfu0937 and OsmY(M3)-Tfu0937 activity in the extracellular, periplasmic and cytoplasmic fractions 
were measured with the pNPG assay using an absorbance at 405 nm. The enzyme activity in each fraction 




































































Figure 6.  Fractional OsmY-Tfu0937 activity in the extracellular, periplasmic and cytoplasmic fractions of 
cells expressing Tfu0937 fused to either OsmY(WT) or OsmY(M3). Activity was measured with the pNPG 
assay using an absorbance at 405 nm. Experiments were performed in triplicate. Cells were cultivated in 2 × TY 
auto-induction medium at 37 °C for either 6 h or 24 h. The enzyme activity in each fraction was calculated as a 
percentage of total activity in all three fractions.




































































Figure 7.  Protein secretion using OsmY(WT) and OsmY(M3) in (a) E. coli C41 (DE3) and (b) BL21(DE3). 
OsmY(WT)-Tfu0937 and OsmY(M3)-Tfu0937 were expressed using C41(DE3) and BL21(DE3) in 50-mL 
2 × TY auto-induction media and at 37 °C and 250 rpm. Cultures were inoculated using 1:200 dilution. The 
cell optical densities monitored at 600 nm (right axis) are shown as lines. The activity of OsmY-Tfu0937 shown 
as bars was measured with the pNPG assay using an absorbance at 405 nm (left axis). The lines and bars 
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C41(DE3) and BL21(DE3) strains (Fig. 7). Protein secretion started in the late logarithmic phase of cell growth 
and most protein secretion occurred during the stationary phase. In agreement with initial experiments, the 
C41(DE3) strain produced more secreted protein compared to BL21(DE3), evident in the higher OsmY-Tfu0937 
activity detected for the C41(DE3) host (Fig. 7a). Both OsmY(TOA4) and OsmY(M3) increased secretory pro-
tein level in BL21(DE3) compared to the wildtype. However, their improvements in BL21(DE3) were similar 
(Fig. 7b). After 25 h of cultivation, OsmY(TOA4) and OsmY(M3) in BL21(DE3) cells produced 2.9 ± 0.3 times 
and 3.1 ± 0.3 times more secreted protein respectively when compared to the wildtype. This was different in 
C41(DE3) where OsmY(M3) produced more secreted protein than OsmY(TOA4) (Fig. 7a). The improvements 
observed for OsmY(M3) were similar in both C41(DE3) and BL21(DE3) but OsmY(TOA4) showed greater 
improvement in BL21(DE3) compared to C41(DE3). We thus concluded that the improved secretory protein 
production by the OsmY variants in C41(DE3) can be transferred to BL21(DE3), though the mutations in 
OsmY(TOA4) likely affected secretion and/or expression in the two strains differently.
Secretion of OsmY(WT)-Tfu0937 and OsmY(M3)-Tfu0937 were further compared in a larger 400-mL cul-
tivation using activity measurement and SDS-PAGE of the spent medium (Fig. 8). For all the samples collected, 
OsmY(M3) secreted more target protein compared to OsmY(WT) (Fig. 8b), except at 7 h for C41(DE3) where 
insignificant OsmY-Tfu0937 activity was detected. Consistent with the results in Fig. 7, BL21(DE3) secreted more 
target protein compared to C41(DE3) at 7 h (Fig. 8b), further supported by our SDS-PAGE analysis (Fig. 8a). 
OsmY(M3) secreted 6.7 ± 0.7 times more target protein compared to OsmY(WT) in C41(DE3) after 24 h culti-
vation (Fig. 8b), the highest we have observed thus far for Tfu0937. This is likely caused by a larger cultivation 
volume. In the 24 h sample for OsmY(M3)-Tfu0937 expressed in C41(DE3), we observed an additional trun-
cated OsmY-Tfu0937 protein in the SDS-PAGE (Fig. 8a). This truncation was also seen in our previous work on 
OsmY-DyP4, where proteomic analysis suggested a potential N-terminal truncation within the first 50 amino 
acids of  OsmY23. The amount of OsmY(M3)-Tfu0937 in the spent medium (full length and truncated) at 24 h 
in C41(DE3) was estimated to be 100 mg/L of culture (Supplementary Fig. S3) using densitometry with ImageJ 
 software28.
OsmY(M3) variant improved the production of secretory RFP and Lipase 6B. Protein secretion 
is known to vary with the identity of the target protein. To determine if OsmY(M3) can be used to improve the 
production of other secretory proteins, the OsmY(WT) and OsmY(M3) were individually fused to the N-ter-
mini of the monomeric red fluorescent protein (RFP) and Lipase 6B. Secretion of OsmY-RFP in BL21(DE3) was 
observed after 24 h of cultivation (Fig. 9a,b), at which point OsmY(M3) showed more secretory RFP compared 
to the wildtype. The use of RFP allowed us to monitor intracellular protein easily (Fig. 9c). Comparing Fig. 9b,c 
helped shed light on the OsmY-assisted protein secretion. First, the protein production of OsmY(WT)-RFP 
was quicker compared to OsmY(M3)-RFP, as there was more total OsmY(WT)-RFP (intra- and extra-cellular) 
after 8 or 10 h of cultivation. This was expected because the codons in OsmY(M3) were deoptimized. Second, 
extracellular protein was accumulated after 24 h of cultivation (i.e., stationary phase), consistent with Tfu0937 
discussed above. This was true for both OsmY(WT) and OsmY(M3). The enhanced production of secretory 
RFP is contributed by two factors: (a) enhanced secretion [41% in OsmY (M3) vs 27% in OsmY(WT)] and (b) 
increased in total protein expression level (23% higher).
Lipase 6B is a thermostable variant of a lipase from Bacillus subtillis29. OsmY(WT)-Lipase 6B and OsmY(M3)-
Lipase 6B were expressed in both BL21(DE3) and C41(DE3), and the secreted protein was monitored using the 
p-nitrophenyl acetate (pNPA) assay (Fig. 10). The C41(DE3) strain grew faster than BL21(DE3) with increasing 
extracellular Lipase 6B activity detected after 7 h of cultivation. Variant OsmY(M3) produced 2.5 ± 0.3 times more 
secreted protein compared to OsmY(WT) after 10 h of cultivation, as determined by the pNPA assay. On the 
Figure 8.  OsmY-Tf0937 secretion using C41(DE3) and BL21(DE3) in 400-mL 2 × TY auto-induction media, 
at 37 °C and 200 rpm. Cultures were inoculated using 1:100 dilution and samples were collected at 7 h and 24 h 
of cultivation. (a) SDS-PAGE of spent medium. Lane L: protein marker, Lane 1 and 5: OsmY(WT)-Tfu0937 in 
BL21(DE3), Lane 2 and 6: OsmY(M3)-Tfu0937 in BL21(DE3), Lane 3 and 7: OsmY(WT)-Tfu0937 in C41(DE3), 
Lane 4 and 8: OsmY(M3)-Tfu0937 in C41(DE3). (b) pNPG assay of the spent medium.
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contrary, protein secretion was minimal in BL21(DE3) throughout the 10 h of cultivation monitored. Overexpres-
sion of recombinant lipase in E. coli can be toxic to the  host29,30. This can lead to the loss of the plasmid containing 
the toxic protein  gene31, potentially explaining the poor protein expression in BL21(DE3) (Fig. 10). The strain 
C41(DE3) was derived from BL21(DE3) and is commonly used for the expression of membrane proteins and 
toxic recombinant  proteins32, likely explaining its better performance for the production of secretory Lipase 6B.









































Figure 9.  OsmY-RFP expression in E. coli BL21(DE3). Cells were cultivated in 20 mL of 2xTY auto-induction 
media at 37 °C using 1:100 dilution of inoculum. The supernatant and cells from 20 µL culture were used 
for fluorescence measurement using  Ex = 584 nm and  Em = 607 nm. (a) Growth curve of the culture. (b) 
Fluorescence intensity of the spent medium. (c) Fluorescence intensity of the cells. The lines and bars of different 
variants are represented using different colours; OsmY(WT)-RFP—grey and OsmY(M3)-RFP—orange.































Figure 10.  OsmY-Lipase 6B expressed in BL21(DE3) and C41(DE3). Cells were cultivated in 50 mL of 2xTY 
auto-induction media at 37 °C using 1:100 dilution of inoculum. The cell optical densities monitored at 600 nm 
are shown as lines. The activity of OsmY-Lipase6B in the spent medium measured with the pNPA assay using an 
absorbance at 405 nm are shown as bars. The lines and bars of different samples are represented using different 
colours; OsmY(WT)-Lipase 6B in C41(DE3)—black, OsmY(M3)-Lipase 6B in C41(DE3)—blue, OsmY(WT)-
Lipase 6B in BL21(DE3)—grey and OsmY(M3)-Lipase 6B in BL21(DE3)—orange.
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Conclusions
In this study, we used random and combinatorial mutagenesis to improve the production of total secretory 
protein by OsmY. The best variant, OsmY(M3), enhanced the production of secreted β-glucosidase, OsmY(M3)-
Tfu0937, in two different E. coli strains by approximately 3 folds (Table 2). While directed evolution had been 
used to randomise the junction between the signal peptide and target  protein7 and to improve transporter 
proteins (e.g., ABC transporter)8, this is the first report that random and combinatorial mutagenesis of a secre-
tory carrier was used to enhance secretory target protein production in E. coli. The critical role of the signal 
peptide was reflected by the two important mutations (L6P ad S19C) found in the signal peptide. Importantly, 
this methodology can be further extended to evolve other signal peptide or carrier proteins for secretory protein 
production in E. coli.
Subcellular fractionation of Tfu0937 with and without OsmY fusion showed that OsmY was essential for the 
extracellular secretion and that > 80% of OsmY-Tfu0937 protein was found extracellularly after 15 h of cultivation 
(Fig. 4). The transferability of improved secretory protein production by OsmY(M3) to a different E. coli stain 
and for other proteins, RFP and Lipase 6B (Table 2), showed the versatility of the OsmY(M3) variant identified. 
It is worth noting that these are three proteins originating from diverse organisms, having diverse molecular 
weights (19.7–53.4 kDa) and protein functions (Table 2). One potential limitation of a fused carrier protein is 
its effect on the characteristics and activities of the target protein. Introduction of a protease cleavage site for 
carrier protein removal can however be used to overcome this  limitation16. Together with previous studies on 
OsmY as a secretory  carrier18–22, this work demonstrated the potential application of OsmY and its variants for 
secretion of a broad range of proteins.
Methods
Materials. Chemicals were purchased from Sigma-Aldrich (Dorset, UK) and ForMedium (Norfolk, UK). 
DNA modifying enzymes, deoxyribonucleotides, and DNA ladders were purchased from New England Biolabs 
(Hitchin, UK), Thermo Fisher Scientific (Loughborough, UK), and Agilent Technologies (Cheadle, UK). Nucleic 
acid purification kits were purchased from Machery-Nagel (Düren, Germany) and Omega Bio-tek (Norcross, 
USA). All oligonucleotides were synthesized by Eurofins Genomics (Ebersberg, Germany), and summarized in 
Supplementary Table S1.
Strains. Escherichia coli DH5α was used for all molecular cloning, plasmid propagation and maintenance. E. 
coli BL21 (DE3) (Merck; Darmstadt, Germany) and C41(DE3) (Lucigen; Wisconsin, USA) were used for protein 
expression.
Molecular cloning of Tfu0937, OsmY‑Tfu0937, OsmY‑RFP and OsmY‑Lipase 6B. The DNA 
sequences encoding the E. coli osmotically-inducible protein Y (OsmY; GenBank: AUY30809.1), the Thermobi-
fida fusca YX β-glucosidase (Tfu0937; GenBank: AAZ54975.1), the Bacillus subtilis lipase mutant (Lipase 6B; 
Ref.29), and a monomeric red fluorescent protein (RFP, GenBank: AAM54544.1) were codon-optimized for pro-
tein expression in E. coli and synthesized by GenScript (Piscataway, USA). OsmY, the secretory carrier, was 
fused to the N-terminus of Tfu0937 and cloned into a pET24a(+) vector (Merck; Darmstadt, Germany) using 
NdeI and EcoRI sites (Supplementary Fig. S4). The resulting plasmid (pET24a-OsmY-Tfu0937; Supplementary 
Fig. S4a) was used for protein engineering in this study.
To create the pET24a-Tfu0937 plasmid, the Tfu0937 gene was amplified with NdeI-Tfu0937-F and EcoRI-
Tfu0937-R primers, digested with NdeI and EcoRI, and cloned into the pET-24a(+) vector using NdeI and EcoRI 
sites. To create pET24a-OsmY-RFP and pET24a-OsmY-Lipase 6B, the RFP gene was amplified using primers 
BamHI-RFP-F and EcoRI-RFP-R and the Lipase 6B gene was amplified using primers BamHI-Lipase6B-F and 
Lipase6B-EcoRI-R. The amplified RFP and Lipase 6B genes were digested with BamHI and EcoRI, and cloned 
into the BamHI/EcoRI digested pET24a-OsmY-Tfu0937 plasmid to replace the Tfu0937 gene. The sequences of 
all primers were summarised in Supplementary Table S1.
Random mutagenesis by epPCR. Two error-prone polymerase chain reaction (epPCR) conditions were 
used in this study: high and low mutagenic rates as previously  reported23. For epPCR of high mutagenic rate, 
the 50-μL PCR mixture contained 1 × standard Taq reaction buffer (Mg-free), 7 mM  MgCl2, 0.05 mM  MnCl2, 
0.2 mM dATP, 0.2 mM dGTP, 1 mM dTTP, 1 mM dCTP, 20 pmol OsmY-DirEv-F primer, 20 pmol OsmY-DirEv-
R primer (Supplementary Table S1), 50 ng pET-24a(+)-OsmY-Tfu0937 and 1.25 U Taq DNA polymerase (New 
England Biolabs). For epPCR of low error rate, the 50-μL PCR mixture contained 1 × standard Taq reaction 
buffer (Mg-free), 1.5 mM  MgCl2, 0.01 mM  MnCl2, 0.3 mM of each dNTP, 4.5 pmol OsmY-DirEv-F primer, 
Table 2.  Production of secretory protein using OsmY(WT) and OsmY(M3) for three different target proteins.
Target protein Mw (kDa) Theoretical pI Protein source organism
Total secretory protein production by OsmY(M3) 
relative to OsmY(WT)/cultivation time (h) Recombinant protein expression host





RFP 25.4 5.65 Synthetic construct 1.8 ± 0.6/24 BL21(DE3)
Lipase 6B 19.7 6.96 Bacillus subtilis 168 2.5 ± 0.3/10 C41(DE3)
11
Vol.:(0123456789)
Scientific Reports |         (2021) 11:5290  | https://doi.org/10.1038/s41598-021-84859-6
www.nature.com/scientificreports/
4.5 pmol OsmY-DirEv-R (Supplementary Table S1), 7.77 ng pET-24a(+)-OsmY-Tfu0937 and 1.25 U Taq DNA 
polymerase (New England Biolabs). The PCR mixtures were thermocycled using the following conditions: (i) 
30 s initial denaturation at 95 °C, (ii) 25 cycles of 20 s denaturation at 95 °C, 30 s annealing at 52 °C and 1 min 30 s 
extension at 68 °C, and (iii) 5 min final extension at 68 °C. PCR products were purified by gel extraction. After 
restrictive digestion with NdeI and BamHI, the PCR products were cloned into NdeI/BamHI digested pET24a-
OsmY-Tfu0937 plasmid. The recombinant plasmids were subsequently electroporated into E. coli C41(DE3) and 
plated on TYE agar (10 g/L tryptone, 5 g/L yeast extract, 8 g/L NaCl and 15 g/L agar) supplemented with 50 μg/
mL kanamycin to create the OsmY mutant libraries.
Site‑directed mutagenesis to create variants OsmY(L6P), OsmY(S154R) and 
OsmY(V191E). Site-directed mutagenesis experiments were performed using partially overlapping primers 
designed by the OneClick  program33. Primers OsmY(L6P)-FP and OsmY(L6P)-RP were used for OsmY(L6P), 
primers OsmY(V154R)-FP and OsmY(S154R)-RP were used for OsmY(S154R), and primers OsmY(V191E)-FP 
and OsmY(V191E)-RP were used for OsmY(V191E) (Supplementary Table S1). In the two-stage PCR designed 
by  OneClick33, PfuUltra High-Fidelity polymerase (Agilent Technologies) was used to introduce the L6P and 
S154R mutations, and PfuUltra II Fusion HS DNA Polymerase (Agilent Technologies) was used to introduce 
the V191E mutation.
Cultivation and protein expression in 96‑well microplate. Individual colonies of the mutant library 
were manually transferred from the agar plates using sterile toothpicks into 96-well deep-well microplates, with 
each well containing 1.5 mL 2 × TY medium (16 g/L tryptone, 10 g/L yeast extract and 5 g/L NaCl) supplemented 
with 50 μg/mL kanamycin. Column 6 on the microplate was inoculated with the wildtype as internal control. 
These master plates were covered with lids, sealed and cultivated at 30 °C for 24 h.
To express protein for screening, master plates were replicated using a pin replicator into fresh 96-well 
deep-well plates, with each well containing 1.5 mL 2 × TY auto induction medium [16 g/L tryptone, 10 g/L yeast 
extract, 3.3 g/L  (NH4)2SO4, 6.8 g/L  KH2PO4, 7.1 g/L  Na2HPO4, 0.5 g/L glucose, 2.0 g/L α-lactose and 0.15 g/L 
 MgSO4] supplemented with 50 μg/mL kanamycin. The plates were cultivated at 30 °C for 24 h before (a) they 
were transferred to a fridge and kept at 4 °C overnight for the cells to settle or (b) they were plate centrifuged at 
4000 rpm for 10 min (Heraeus Megafuge 8R; M10 microplate rotor). The supernatant containing the secreted 
OsmY-Tfu0937 was used for high-throughput screening on the next day.
Abgene 96-well polypropylene deep-well plates (Thermo Fisher Scientific; AB0661) and Abgene polypropyl-
ene plate covers (Thermo Fisher Scientific; AB0755) were used in preparing master plates and protein expression 
plates. All plate cultivations were conducted in Titramax 1000 plate shaker coupled to an Incubator 1000 heating 
module (Heidolph Instruments; Essex, UK) using a shaking speed of 1050 rpm.
High‑throughput screening in 96‑well microplate. Flat-bottom clear 96-well polystyrene microplates 
(Greiner Bio-One; 655161) were used for screening. Unless otherwise stated, 20 μL of spent medium was trans-
ferred to 96-well microplates, with each well containing 30 μL of 0.2 M sodium acetate. Fifty μL of pNPG solu-
tion (5.3 mM pNPG, 0.2 M sodium acetate, pH 4.8) was then added to each well. The microplates were incubated 
at 50 °C and 1050 rpm in a microplate shaker for 5 min before 100 μL of NaOH-Gly buffer (0.4 M glycine, pH 
10.8) was added to stop the reaction. Absorbance at 405 nm was recorded with Multiskan FC microplate pho-
tometer (Thermo Fisher Scientific). All shaking steps were conducted in Titramax 1000 (Heidolph Instruments) 
using a shaking speed of 1050 rpm.
Variant characterization using tube and flask cultures. The variants were characterized using two 
methods, (a) tube cultures and (b) flask cultures. For tube cultures, 5 μL of cells from the master plate was 
transferred to culture tubes containing 5 mL of 2xTY auto induction medium supplemented with 50 μg/mL 
kanamycin and cultivated overnight at 37 °C. Flask cultures were used for expression studies, where 20 mL or 
50 mL of 2 × TY-based auto induction medium was inoculated using 1:100 or 1:200 dilution of the pre-culture 
and cultivated at 37 °C and 240 rpm, unless otherwise stated. During cultivation, cell growth was monitored by 
absorbance reading at 600 nm  (OD600). For assay measurement, 0.5–1.0 mL of culture was sampled and secreted 
protein was measured using the pNPG assay (Tfu0937), the pNPA assay (Lipase 6B) or fluorescence intensity 
(RFP).
The pNPG assay, pNPA assay and RFP fluorescence measurement. The sampled culture (0.5–
1.0 mL) was centrifuged at > 17,000×g for 5–10 min and 50 µL of the supernatant containing the secreted protein 
was used for assay. The supernatant was diluted to keep within the assay linear detection range when necessary. 
The pNPG assay was used to measure the Tfu0937 activity. For pNPG assay, 50 µL of supernatant was transferred 
to a microplate and sample was assayed using the same protocol as high-throughput screening. The supernatant 
was diluted using either 2 × TY medium or sample buffers for the subcellular fractions when necessary. The 
molar extinction coefficient of 18,000/M/cm was used to calculate the p-nitrophenol released. The pNPA assay 
was used to measure the Lipase 6B activity. For pNPA assay, 20 µL of supernatant was transferred to a microplate 
and 180 µL of freshly prepared pNPA solution (2.0 mM pNPA, 50 mM potassium phosphate buffer, pH 7.2) was 
added. Reaction was incubated at room temperature for 10 min before the absorbance was recorded at 405 nm. 
The supernatant was diluted using 50 mM potassium phosphate buffer, pH 7.2 assay buffer when necessary. For 
RFP detection, 100 µL of supernatant was transfer to a black microplate (Greiner Bio-One; 655906) and fluores-
cence intensity was measured using the SpectraMax M2e plate reader (Molecular Device; California, USA) at 
excitation wavelength of 584 nm and emission wavelength of 607 nm. The RFP fluorescence intensity of the cell 
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was measured using cells from 100 µL of culture resuspended in 100 µL of 50 mM  KxPO4, pH 7.5 and at the same 
excitation and emission wavelengths. Assay background, for the pNPG and pNPA assays, was always removed by 
subtracting the assayed absorbance (at 405 nm) of the spent medium from the culture of cells without plasmids 
[i.e., BL21(DE3) or C41(DE3)].
Soluble protein extraction using enzymatic lysis. One mL of culture was centrifuged at > 17,000g 
for 5–10 min. The supernatant was removed, and the cell pellet was resuspended in 200 µL of lysomix (10 mg/
mL lysozyme in 50 mM, pH 7.5) by vortexing. Sample was incubated on ice for 1 h followed by centrifugation 
at > 17,000g for 10 min. The supernatant, which contained the soluble protein fraction, was transferred to a fresh 
tube. OsmY-Tfu0937 activity in the soluble fraction was determined using the pNPG assay.
Subcellular fractionation of Tfu0937 and OsmY‑Tfu0937. Cells were cultivated as described earlier 
using 50 mL or 100 mL of 2 × TY-based auto induction medium. The cells were harvested by centrifugation at 
6000g, 4 °C for 5 min. The supernatant was transfer to a clean tube and used as the extracellular fraction. The 
cell pellet was resuspended in 25 mL of osmotic shock buffer (100 mM Tris–HCl, 20% sucrose, 1 mM EDTA, pH 
8.0) and incubated on ice for 15 min. The cell suspension was then centrifuged at 7000g, 4 °C for 10–15 min and 
the clear supernatant was transferred to a clean tube (fraction P1). The resulting cell pellet was resuspended in 
2.5 mL of ice-cold water with 1 mM  MgCl2 and incubated on ice for 15 min. The cell suspension was centrifuged 
at 7000g, 4 °C for 10 min and the clear supernatant was transferred to a clean tube (fraction P2). Fractions P1 
and P2 were used to determine Tfu0937 activity in the periplasmic fraction. The cell pellet following periplasmic 
extraction was resuspended in 10 mL of 100 mM Tris–HCl buffer (pH 8.0) by vortexing and cells were lysed by 
sonication (Vibra-Cell ultrasonic liquid processors; Sonics & Materials; Newtown, USA) using 40% amplitude 
and 1.5 min total processing time. After sonication, 2 mL of sonicated sample was centrifuged at 20,000g, 4 °C 
for 10 min. The supernatant was collected as the cytoplasmic fraction.
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